首页> 美国卫生研究院文献>BMC Systems Biology >Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease
【2h】

Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease

机译:系统生物学方法用于在多囊肾疾病进展过程中识别转录组重编程和候选microRNA靶标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAutosomal dominant polycystic kidney disease (ADPKD) is characterized by cyst formation throughout the kidney parenchyma. It is caused by mutations in either of two genes, PKD1 and PKD2. Mice that lack functional Pkd1 (Pkd1-/-), develop rapidly progressive cystic disease during embryogenesis, and serve as a model to study human ADPKD. Genome wide transcriptome reprogramming and the possible roles of micro-RNAs (miRNAs) that affect the initiation and progression of cyst formation in the Pkd1-/- have yet to be studied. miRNAs are small, regulatory non-coding RNAs, implicated in a wide spectrum of biological processes. Their expression levels are altered in several diseases including kidney cancer, diabetic nephropathy and PKD.
机译:背景常染色体显性遗传性多囊肾病(ADPKD)的特征是整个肾实质均形成囊肿。它是由PKD1和PKD2两个基因中的任何一个突变引起的。缺乏功能性Pkd1(Pkd1 -/-)的小鼠在胚胎发生过程中会迅速发展为囊性疾病,并成为研究人类ADPKD的模型。基因组宽的转录组重编程以及影响Pkd1 -/-中囊肿形成的起始和进展的微小RNA(miRNA)的可能作用尚待研究。 miRNA是小的调节性非编码RNA,与广泛的生物学过程有关。它们的表达水平在包括肾脏癌,糖尿病肾病和PKD在内的几种疾病中发生改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号